Atma (Sambucus) drops 50 ml.

active substances: 100 ml contains: Sambucus nigra D1 10 ml, Natrium sulfuricum D6 10 ml, Dulcamara D6 10 ml, Arsenicum album D12 10 ml, Tartarus emeticus D12 10 ml;

excipients: ethanol 43% (m/m), purified water.

Oral drops.

Main physico-chemical properties: transparent, slightly yellowish to greenish-yellow solution without a specific smell.

Complex homeopathic remedy.

Atma (Sambucus) has a systemic therapeutic effect due to the combination and mutual strengthening of active components. It has a broncholytic, mucolytic, anti-inflammatory, immunomodulatory and anti-allergic effect.

The drug eliminates spasm and reduces bronchial reactivity, reduces shortness of breath, reduces the frequency and intensity of shortness of breath attacks. Improves the quantitative (volume of production) and qualitative (physico-chemical) characteristics of sputum, promotes thinning and more efficient discharge of thick mucus. Restores the work of the ciliated epithelium of the bronchi.

The anti-inflammatory effect of the drug prevents damage to the bronchi and lungs by free radicals and proteases, protects the pulmonary circulation from the action of inflammatory mediators.

Reduces inflammatory infiltration and swelling of the mucous membrane, prevents sclerotic changes in the bronchi and lungs. Improves systemic immunity, normalizes the functional state of the cellular link and indicators of humoral immunity (level of IgE and CIC), and also reduces antigenic stimulation. Contributes to the stabilization of the membranes of mast cells, reduces eosinophilia.

Atma (Sambucus) is used in the complex treatment of bronchial asthma. Strengthens the broncholytic effect of inhaled corticosteroids and β2-agonists, allows to reduce the intake or doses of these drugs of basic therapy. In the treatment of bronchitis, including obstructive, the drug reduces the broncho-obstructive syndrome, improves the dynamics of clinical (including auscultatory symptoms, external respiratory function indicators, peak flowmetry data) and subjective manifestations. In the treatment of chronic bronchitis, the drug facilitates expectoration, improves breathing, general condition and quality of life, prevents the development of irreversible changes in the bronchi and lungs. Provides elimination of asthenic symptom complex of hypoxic and infectious genesis. Stimulates individual compensatory capabilities of the body, increases non-specific reactivity of the body to infections.

Acute and chronic bronchitis, including obstructive syndrome. In complex therapy of bronchial asthma.

Hypersensitivity to any active or auxiliary substance of Atma (Sambucus).